Intralesional biologics for inflammatory dermatoses: A systematic review-Reference-Cited by-同舟云学术

Intralesional biologics for inflammatory dermatoses: A systematic review

Published:2021-12-08 Issue:2 Volume:35 Page:
ISSN:1396-0296
Container-title:Dermatologic Therapy
language:en
Short-container-title:Dermatologic Therapy

Author:

Seivright Justine R.¹,Villa Natalie M.²,De Devea R.³,Hsiao Jennifer L.⁴^ORCID,Shi Vivian Y.⁵^ORCID

Affiliation:

1. David Geffen School of Medicine University of California Los Angeles California USA

2. Department of Dermatology Dartmouth‐Hitchcock Medical Center Lebanon New Hampshire USA

3. Jacobs School of Medicine and Biomedical Sciences University at Buffalo Buffalo New York USA

4. Department of Medicine, Division of Dermatology University of California Los Angeles Los Angeles California USA

5. Department of Dermatology University of Arkansas for Medical Sciences Little Rock Arkansas USA

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dth.15234

Reference24 articles.

1. Intralesional Therapy With Anti-CD20 Monoclonal Antibody Rituximab in Primary Cutaneous B-Cell Lymphoma

2. Intralesional Rituximab

3. OCEBM Levels of Evidence Working Group.The Oxford 2011 levels of evidence. Oxford Centre for Evidence‐Based Medicine. Accessed June 3 2021.https://www.cebm.net/

4. Local Injection of Infliximab for the Treatment of Perianal Crohn's Disease

5. Infliximab in the treatment of Crohn's disease

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. EuroGuiderm guideline on lichen sclerosus—Treatment of lichen sclerosus;Journal of the European Academy of Dermatology and Venereology;2024-06

2. Intralesional Certolizumab for Refractory Lupus Pernio;JAMA Dermatology;2023-08-01

3. Successful treatment of classic pyoderma gangrenosum with intralesional infliximab injection: A case report;Australasian Journal of Dermatology;2023-05-16